Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells

被引：0
|
作者：
Qin Jiang
Manyi Yang
Zhan Qu
Jixiang Zhou
Qi Zhang
机构：
[1] Xiangya Hospital,Department of Hepatobiliary & Pancreatic Surgery
[2] Central South University,Department of Ultrasonography
[3] Xiangya Hospital,National Hepatobiliary & Enteric Surgery Research Center, Xiangya Hospital
[4] Central South University,undefined
[5] Central South University,undefined
来源：
BMC Complementary and Alternative Medicine | / 17卷
关键词：
Resveratrol; Paclitaxel; HepG2 human liver cancer cells; Sensitizing; Apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Effects of artemisinin on proliferation and apoptosis of human liver cancer HepG2 cells A protocol of systematic review and meta-analysis
    Li, Jing
    Liu, Zhi-ye
    Yu, Hai-bo
    Xue, Qing
    Qu, Xiu-sheng
    MEDICINE, 2020, 99 (20)
  • [42] Resveratrol Limits Lipogenesis and Enhance Mitochondrial Activity in HepG2 Cells
    Izdebska, Magdalena
    Herbet, Mariola
    Gawronska-Grzywacz, Monika
    Piatkowska-Chmiel, Iwona
    Korga, Agnieszka
    Sysa, Marcin
    Iwan, Magdalena
    Natorska-Chomicka, Dorota
    Poleszak, Ewa
    Wrobel, Andrzej
    Mandziuk, Slawomir
    Dudka, Jaroslaw
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2018, 21 : 504 - 515
  • [43] Evaluation of important treatment parameters in supraphysiological thermal therapy of human liver cancer HepG2 cells
    Shah, Bhavik
    Bhowmick, Sankha
    ANNALS OF BIOMEDICAL ENGINEERING, 2006, 34 (11) : 1745 - 1757
  • [44] Evaluation of Important Treatment Parameters in Supraphysiological Thermal Therapy of Human Liver Cancer HepG2 Cells
    Bhavik Shah
    Sankha Bhowmick
    Annals of Biomedical Engineering, 2006, 34 : 1745 - 1757
  • [45] Resveratrol sensitizes HepG2 cells to TRAIL-induced apoptosis
    Tameda, Masahiko
    Sugimoto, Kazushi
    Shiraki, Katsuya
    Inagaki, Yuji
    Ogura, Suguru
    Kasai, Chika
    Yoneda, Misao
    Okamoto, Ryuji
    Yamamoto, Norihiko
    Takei, Yoshiyuki
    Ito, Masaaki
    Nobori, Tsutomu
    ANTI-CANCER DRUGS, 2014, 25 (09) : 1028 - 1034
  • [46] Differential Genomic Effects of Six Different TiO2 Nanomaterials on Human Liver HepG2 Cells
    Thai, Sheau-Fung
    Wallace, Kathleen A.
    Jones, Carlton P.
    Ren, Hongzu
    Grulke, Eric
    Castellon, Benjamin T.
    Crooks, James
    Kitchin, Kirk T.
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2016, 30 (07) : 331 - 341
  • [47] Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells
    Taha, Amna Mohamed
    Aboulwafa, Mohammad Mabrouk
    Zedan, Hamdallah
    Helmy, Omneya Mohamed
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [48] Combined effects and toxicological interactions of perfluoroalkyl and polyfluoroalkyl substances mixtures in human liver cells (HepG2)
    Ojo, Atinuke F.
    Peng, Cheng
    Ng, Jack C.
    ENVIRONMENTAL POLLUTION, 2020, 263 (263)
  • [49] Exploiting antidiabetic activity of silver nanoparticles synthesized using Punica granatum leaves and anticancer potential against human liver cancer cells (HepG2)
    Saratale, Rijuta G.
    Shin, Han Seung
    Kumar, Gopalakrishnan
    Benelli, Giovanni
    Kim, Dong-Su
    Saratale, Ganesh D.
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 (01) : 211 - 222
  • [50] Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells
    Amna Mohamed Taha
    Mohammad Mabrouk Aboulwafa
    Hamdallah Zedan
    Omneya Mohamed Helmy
    Scientific Reports, 12
12345